9-(2-hydroxy-3-nonyl)adenine has been researched along with Coronary Disease in 8 studies
9-(2-hydroxy-3-nonyl)adenine: specific inhibitor of adenosine deaminase
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "2." | 1.27 | Absolute rates of adenosine formation during ischaemia in rat and pigeon hearts. ( Meghji, P; Middleton, KM; Newby, AC, 1988) |
| "Hypoxanthine levels were fivefold more in Group 1 compared with Groups 2 and 3 (p less than 0." | 1.27 | Myocardial reperfusion injury. Role of myocardial hypoxanthine and xanthine in free radical-mediated reperfusion injury. ( Abd-Elfattah, AS; Brunsting, LA; Doherty, NE; Jessen, ME; Lekven, J; Wechsler, AS, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pasque, MK | 1 |
| Wechsler, AS | 2 |
| Humphrey, SM | 2 |
| Seelye, RN | 1 |
| Gavin, JB | 1 |
| Van Wylen, DG | 2 |
| Schmit, TJ | 1 |
| Lasley, RD | 1 |
| Gingell, RL | 1 |
| Mentzer, RM | 2 |
| Dorheim, TA | 1 |
| Hoffman, A | 1 |
| Meghji, P | 1 |
| Middleton, KM | 1 |
| Newby, AC | 1 |
| Holliss, DG | 1 |
| Cartner, LA | 1 |
| Abd-Elfattah, AS | 1 |
| Jessen, ME | 1 |
| Lekven, J | 1 |
| Doherty, NE | 1 |
| Brunsting, LA | 1 |
| Achterberg, PW | 1 |
| de Jong, JW | 1 |
1 review available for 9-(2-hydroxy-3-nonyl)adenine and Coronary Disease
| Article | Year |
|---|---|
Metabolic intervention to affect myocardial recovery following ischemia.
Topics: Adenine; Adenosine; Adenosine Monophosphate; Adenosine Triphosphate; Aminoimidazole Carboxamide; Ani | 1984 |
7 other studies available for 9-(2-hydroxy-3-nonyl)adenine and Coronary Disease
| Article | Year |
|---|---|
The influence of adenosine on the no-reflow phenomenon in anoxic and ischaemic hearts.
Topics: Adenine; Adenosine; Adenosine Deaminase Inhibitors; Animals; Coronary Circulation; Coronary Disease; | 1982 |
Cardiac microdialysis in isolated rat hearts: interstitial purine metabolites during ischemia.
Topics: Adenine; Animals; Coronary Disease; Dialysis; Extracellular Space; In Vitro Techniques; Myocardium; | 1992 |
Enhanced interstitial fluid adenosine attenuates myocardial stunning.
Topics: Adenine; Adenosine; Adenosine Deaminase Inhibitors; Animals; Coronary Disease; Dogs; Extracellular S | 1991 |
Absolute rates of adenosine formation during ischaemia in rat and pigeon hearts.
Topics: 5'-Nucleotidase; Adenine; Adenosine; Adenosine Deaminase; Adenosine Kinase; Adult; AMP Deaminase; An | 1988 |
The influence of inhibitors of the ATP degradative pathway on recovery of function and high energy phosphate after transient ischemia in the rat heart.
Topics: 5'-Nucleotidase; Acute Disease; Adenine; Adenine Nucleotides; Adenosine; Adenosine Deaminase Inhibit | 1986 |
Myocardial reperfusion injury. Role of myocardial hypoxanthine and xanthine in free radical-mediated reperfusion injury.
Topics: Adenine; Adenine Nucleotides; Animals; Coronary Disease; Dogs; Female; Free Radicals; Heart; Heart V | 1988 |
Adenosine deaminase inhibition and myocardial adenosine metabolism during ischemia.
Topics: Adenine; Adenosine; Adenosine Deaminase Inhibitors; Adenosine Monophosphate; Animals; Coronary Circu | 1985 |